PRVA Stock Analysis: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$21.21
0.14 (0.66%)
▲
5d:
+5.1%
30d:
-12.72%
90d:
-10.54%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRVA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PRVA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.83
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$22.87
7.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $21.21, which is considered slightly low relative to its 30-day fair value range of $20.74 to $23.38. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.7) compared to its historical average (21.0). Remarkably, the market is currently pricing in an annual earnings decline of 5.7% over the next few years. This pessimistic expectation contrasts with the company's recent 132.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PRVA is in a strong downtrend. Immediate support is located at $19.53, while resistance sits at $21.86.
Market Sentiment: PRVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.95 (+50.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRVA is in a strong downtrend. Immediate support is located at $19.53, while resistance sits at $21.86.
Market Sentiment: PRVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.95 (+50.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$20.74 -
$23.38
Company Quality Score
60/100
(BUY)
Options IV Signal
36th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding PRVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 36th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.6% below Wall St target ($31.95)
Fair Price Analysis
30-Day Fair Range
$20.74 -
$23.38
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.75
(8.3%)
Support & Resistance Levels
Support Level
$19.53
Resistance Level
$21.87
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.66
Wall Street Target
$31.95
(+50.6%)
Revenue Growth (YoY)
17.4%
Earnings Growth (YoY)
132.8%
Profit Margin
1.1%
Valuation Discount vs History
-5.7% cheaper
PE vs Historical
17.7 vs 21.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.7%
(market-implied from PE analysis)
1-Year Target
$20.00
(-6%)
2-Year Target
$18.86
(-11%)
3-Year Target
$17.79
(-16%)
3-Yr Target (if PE normalizes)
(PE: 18→21)
$21.15
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 11.8%)
$34.51
(+63%)
Base:
(SPY PE: 17.7, Growth: 11.8%)
$29.63
(+40%)
Bear:
(PE: 15.0, Growth: 11.8%)
$25.18
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Forward PE: 19.12 | Forward EPS (Implied): $1.13
Bull Case
$25.99
(+21%)
Analyst growth 15.0%, PE expands to 20.1
Base Case
$21.52
(0%)
Market implied 0.0%, PE stable at 19.1
Bear Case
$16.46
(-24%)
Severe decline -15.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.7 to 21.0
Stabilization Target:
$25.22
(+18.9%)
PE Expansion Potential:
+18.9%
Share & Embed Analysis
Last updated: April 02, 2026 7:06 PM ET
Data refreshes hourly during market hours. Next update: 8:06 PM
Data refreshes hourly during market hours. Next update: 8:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Parth Mehrotra
SELL
26509 shares
2026-03-16
David Mountcastle
SELL
6391 shares
2026-03-16
David Mountcastle
SELL
6565 shares
2026-03-13
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 62 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 67 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 52 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$37 | 54 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
